CellaVision Stock

CellaVision EV/EBIT

The EV/EBIT (Enterprise Value to EBIT) of CellaVision (CEVI.ST) as of Aug 15, 2026 is 18.11. In the previous year, EV/EBIT (Enterprise Value to EBIT) was 20.59 — a change of -12.07% (lower).

EV/EBIT

18.11

YoY

-12.07%

Last updated:

EV/EBIT (Enterprise Value to EBIT) of CellaVision is 2026 18.11 . EV/EBIT (Enterprise Value to EBIT) of CellaVision was 2025 20.59 . It decreases by -12.07% lower compared to the previous year.

The CellaVision EV/EBIT history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

PRICE-TO-EBIT
Date
PRICE-TO-EBIT
Jan 1, 2019
59.56 base
Jan 1, 2020
67.05 base
Jan 1, 2021
47.66 base
Jan 1, 2022
34.51 base
Jan 1, 2023
30.29 base
Jan 1, 2024
29.20 base
Jan 1, 2025
18.48 base
Jan 1, 2026 (e)
18.15 base
YEARPRICE-TO-EBIT
2026 est 18.15
2025 18.48
2024 29.20
2023 30.29
2022 34.51
2021 47.66
2020 67.05
2019 59.56
2018 40.87
2017 37.72
2016 30.52
2015 25.41
2014 21.89
2013 14.16
2012 16.94
2011 17.89
2010 17.78
2009 16.14
2008 9.00
2007 -
2006 -
Access this data via the Eulerpool API

CellaVision Valuation

Details

Historical Valuation Multiples

Price-to-Earnings Ratio (P/E)

The P/E ratio divides CellaVision's share price by its earnings per share. It tells you how many years of current earnings you are "paying for" when you buy the stock. A P/E of 20 means you pay $20 for every $1 of annual earnings. The S&P 500 historically trades at an average P/E of roughly 15–17. A P/E significantly above that may signal high growth expectations; one below may indicate undervaluation — or declining business quality.

Price-to-Sales Ratio (P/S)

The P/S ratio divides market capitalization by total revenue. Unlike the P/E ratio, it works even for companies that are not yet profitable, making it essential for evaluating high-growth firms. A P/S below 1.0 may indicate undervaluation, while ratios above 10 are typically reserved for fast-growing tech or SaaS companies with high expected future margins.

Price-to-EBIT Ratio

This ratio relates CellaVision's market price to its operating earnings, excluding the effects of debt structure and tax jurisdiction. It is particularly useful for comparing companies across different countries or with different levels of leverage, because it focuses purely on operational profitability. Lower values suggest cheaper operational earnings.

How to Use This Chart

This chart plots CellaVision's valuation multiples over time. Compare the current P/E, P/S, and P/EBIT to their own historical averages — if the current ratio is well below the multi-year average, the stock may be relatively cheap compared to its own track record. Combine this with industry comparisons: a P/E that looks high in absolute terms may be justified if CellaVision grows earnings faster than its peers.

CellaVision Stock analysis

What does CellaVision do? CellaVision AB is an internationally leading company in the development of systems for automated cell imaging and analysis, founded in 1994 in Lund, Sweden. CellaVision is one of the most popular companies on Eulerpool.

Frequently Asked Questions about CellaVision stock

EV/EBIT (Enterprise Value to EBIT) of CellaVision is 18.11 in 2026.

EV/EBIT (Enterprise Value to EBIT) of CellaVision changed from 20.59 to 18.11, representing a -12.07% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of EV/EBIT (Enterprise Value to EBIT) CellaVision since 2006 – with annual values, charts, and detailed analysis.

The EV/EBIT ratio measures a company's enterprise value relative to its operating earnings. It accounts for debt, making it useful for comparing companies with different capital structures.

EV/EBIT = Enterprise Value / Earnings Before Interest and Taxes

To evaluate EV/EBIT (Enterprise Value to EBIT)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for EV/EBIT (Enterprise Value to EBIT).

A 'good' varies by industry and company stage. On Eulerpool, you can compare EV/EBIT (Enterprise Value to EBIT)'s CellaVision with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

Valuation — CellaVision

All Key Metrics — CellaVision